Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

Cited In for PubMed (Select 17498797)

1.

Evaluation of Oral Changes Among Tobacco Users of Aljouf Province, Saudi Arabia.

Aljabab MA, Aljbab AA, Patil SR.

J Clin Diagn Res. 2015 May;9(5):ZC58-61. doi: 10.7860/JCDR/2015/13683.5950. Epub 2015 May 1.

2.

Attentional bias in snus users: an experimental study.

Mentzoni RA, Sætrevik B, Molde H, Wiium N, Hetland J, Fagerland I, Nordnes LT, Storemark SS, Fossum IN, Pallesen S.

PLoS One. 2014 Oct 8;9(10):e108897. doi: 10.1371/journal.pone.0108897. eCollection 2014.

3.

The European Parliament proposal for the new EU General Data Protection Regulation may severely restrict European epidemiological research.

Nyrén O, Stenbeck M, Grönberg H.

Eur J Epidemiol. 2014 Apr;29(4):227-30. doi: 10.1007/s10654-014-9909-0. Epub 2014 May 7. No abstract available.

4.

Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.

Stepanov I, Biener L, Yershova K, Nyman AL, Bliss R, Parascandola M, Hatsukami DK.

Nicotine Tob Res. 2014 Aug;16(8):1070-8. doi: 10.1093/ntr/ntu026. Epub 2014 Mar 6.

PMID:
24604020
5.

Impact of smokeless tobacco packaging on perceptions and beliefs among youth, young adults, and adults in the U.S: findings from an internet-based cross-sectional survey.

Adkison SE, Bansal-Travers M, Smith DM, O'Connor RJ, Hyland AJ.

Harm Reduct J. 2014 Jan 17;11:2. doi: 10.1186/1477-7517-11-2.

6.

Epidemiological evidence relating snus to health--an updated review based on recent publications.

Lee PN.

Harm Reduct J. 2013 Dec 6;10:36. doi: 10.1186/1477-7517-10-36. Review.

7.

Risk factors and therapeutic targets in pancreatic cancer.

Wörmann SM, Algül H.

Front Oncol. 2013 Nov 18;3:282. doi: 10.3389/fonc.2013.00282. Review.

8.

Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden.

Huang J, Magnusson M, Törner A, Ye W, Duberg AS.

Br J Cancer. 2013 Nov 26;109(11):2917-23. doi: 10.1038/bjc.2013.689. Epub 2013 Oct 31.

9.

The effect of Swedish snuff (snus) on offspring birthweight: a sibling analysis.

Juárez SP, Merlo J.

PLoS One. 2013 Jun 12;8(6):e65611. doi: 10.1371/journal.pone.0065611. Print 2013.

10.

Drug addiction is associated with leukocyte telomere length.

Yang Z, Ye J, Li C, Zhou D, Shen Q, Wu J, Cao L, Wang T, Cui D, He S, Qi G, He L, Liu Y.

Sci Rep. 2013;3:1542. doi: 10.1038/srep01542.

11.

Alternative tobacco product use and smoking cessation: a national study.

Popova L, Ling PM.

Am J Public Health. 2013 May;103(5):923-30. doi: 10.2105/AJPH.2012.301070. Epub 2013 Mar 14.

12.

Public education about the relative harm of tobacco products: an intervention for tobacco control professionals.

Biener L, Nyman AL, Stepanov I, Hatsukami D.

Tob Control. 2014 Sep;23(5):385-8. doi: 10.1136/tobaccocontrol-2012-050814. Epub 2013 Mar 12.

PMID:
23481906
13.

Smokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England.

Zhou J, Michaud DS, Langevin SM, McClean MD, Eliot M, Kelsey KT.

Int J Cancer. 2013 Apr 15;132(8):1911-7. doi: 10.1002/ijc.27839. Epub 2012 Oct 11.

14.

Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users.

Benowitz NL, Renner CC, Lanier AP, Tyndale RF, Hatsukami DK, Lindgren B, Stepanov I, Watson CH, Sosnoff CS, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):934-42. doi: 10.1158/1055-9965.EPI-11-1178. Epub 2012 Apr 6.

15.

Non-cigarette tobacco products: what have we learnt and where are we headed?

O'Connor RJ.

Tob Control. 2012 Mar;21(2):181-90. doi: 10.1136/tobaccocontrol-2011-050281. Review.

16.

Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus.

Stepanov I, Jensen J, Biener L, Bliss RL, Hecht SS, Hatsukami DK.

Nicotine Tob Res. 2012 Oct;14(10):1241-5. Epub 2012 Jan 17.

17.

Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.

Stepanov I, Biener L, Knezevich A, Nyman AL, Bliss R, Jensen J, Hecht SS, Hatsukami DK.

Nicotine Tob Res. 2012 Mar;14(3):274-81. doi: 10.1093/ntr/ntr209. Epub 2011 Oct 29.

18.

The scientific foundation for tobacco harm reduction, 2006-2011.

Rodu B.

Harm Reduct J. 2011 Jul 29;8:19. doi: 10.1186/1477-7517-8-19.

19.

Changing patterns of tobacco use in a middle-aged population: the role of snus, gender, age, and education.

Norberg M, Lundqvist G, Nilsson M, Gilljam H, Weinehall L.

Glob Health Action. 2011;4. doi: 10.3402/gha.v4i0.5613. Epub 2011 Jun 3.

20.

Prevalence of trial of snus products among adult smokers.

Biener L, McCausland K, Curry L, Cullen J.

Am J Public Health. 2011 Oct;101(10):1874-6. doi: 10.2105/AJPH.2010.200097. Epub 2011 Feb 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk